Disposal of 3500 Backlog Application under the Office of the Director's General's Project Backlog
The Food and Drug Administration (FDA) is pleased to announce that it has completed the evaluation of, and has consequently disposed, 3,500 backlog application for authorizations that have been pending with the Center for Drug Regulations and Research (CDRR), Center for Food Regulation & Research (CFRR), Center for Cosmetic Regulations & Research (CCRR), and Center for Device Regulation Radiation Health & Research (CDRRHR), since 1 February 2018 and prior months, under the agency-wide Project Backlog
The FDA has likewise verified and posted at least 1,400 applications for authorizations that have been pending at the FDA's electronic portal (e-portal) since 1 February 2018 and prior months, per stakeholders compliance with the FDA Advisory No. 2018-241, and has already forwarded said applications to concerned centers for evaluation and disposition under the Project Backlog
The disposed applications for authorizations - consisting of applications for License to Operate (LTO), Certificate of Product Registration/Notification (CPR/CPN), Variations, renewals and other Certifications, were processed by a dedicated team of technical personnel - formed under the Project Backlog, who works under the direct supervision and control of the Director-General.
The Project Backlog will continue until the end of this year, and is geared towards the disposition of at least eigthy percent (80%) the backlogs pending at the FDA